Company Eastgate Biotech Corp. Other OTC
Equities
ETBI
US2772531008
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Natural Compounds and Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 14/01/15 |
William Abajian
PSD | President | 66 | 31/05/16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 11/04/17 |
Anna Gluskin
BRD | Director/Board Member | 68 | 21/05/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 21/05/12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 14/01/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,257,377 | 717,257,377 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |